blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1305282

EP1305282 - PLEUROMUTILIN DERIVATIVES HAVING ANTIBACTERIAL ACTIVITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.07.2009
Database last updated on 19.10.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY, TR
published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Nabriva Therapeutics AG
Leberstrasse 20
1112 Wien / AT
[2008/22]
Former [2007/18]For all designated states
Nabriva Therapeutics Forschungs GmbH
Brunner Strasse 59
1235 Wien / AT
Former [2004/41]For all designated states
SANDOZ AG
Lichtstrasse 35
4002 Basel / CH
Former [2004/30]For all designated states
Sandoz GmbH
Biochemiestrasse 10
6250 Kundl / AT
Former [2004/29]For all designated states
Sandoz GmbH
Biochemiestrasse 10
6250 Kundl / AT
Former [2003/18]For all designated states
BIOCHEMIE GESELLSCHAFT M.B.H.
6250 Kundl / AT
Inventor(s)01 / ASCHER, Gerd
Daxerfeld 3
A-6250 Kundl / AT
02 / BERNER, Heinz
Geyergasse 2a
A-1180 Wien / AT
 [2003/18]
Representative(s)Schwarz, Albin, et al
Schwarz & Partner Patentanwälte Wipplingerstrasse 30
1010 Wien / AT
[N/P]
Former [2006/43]Schwarz, Albin, et al
Kopecky & Schwarz Patentanwälte Wipplingerstrasse 32/22
1010 Wien / AT
Former [2006/24]Kopecky, Helmut, et al
Kopecky & Schwarz Patentanwälte Wipplingerstrasse 32/22
1010 Wien / AT
Former [2003/18]Gros, Florent
Novartis AG
4002 Basel / CH
Application number, filing date01954024.409.07.2001
[2003/18]
WO2001EP07875
Priority number, dateGB2000001703111.07.2000         Original published format: GB 0017031
[2003/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0204414
Date:17.01.2002
Language:EN
[2002/03]
Type: A1 Application with search report 
No.:EP1305282
Date:02.05.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 17.01.2002 takes the place of the publication of the European patent application.
[2003/18]
Type: B1 Patent specification 
No.:EP1305282
Date:17.09.2008
Language:EN
[2008/38]
Search report(s)International search report - published on:EP17.01.2002
ClassificationIPC:C07C323/52, A61K31/10, A61P31/04
[2003/18]
CPC:
C07C323/52 (EP,US); C07C323/53 (KR); A61K31/215 (EP,US);
A61P31/00 (EP); A61P31/04 (EP); C07C2601/14 (EP,US);
C07C2603/99 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/18]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RO11.02.2003
SI11.02.2003
TitleGerman:PLEUROMUTILINDERIVATE MIT ANTIBAKTERIELLER WIRKUNG[2003/18]
English:PLEUROMUTILIN DERIVATIVES HAVING ANTIBACTERIAL ACTIVITY[2003/18]
French:DERIVES DE PLEUROMUTILINE PRESENTANT UNE ACTIVITE ANTIBACTERIENNE[2003/18]
Entry into regional phase11.02.2003National basic fee paid 
11.02.2003Designation fee(s) paid 
11.02.2003Examination fee paid 
Examination procedure21.01.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
11.02.2003Examination requested  [2003/18]
06.02.2006Despatch of a communication from the examining division (Time limit: M06)
25.07.2006Reply to a communication from the examining division
25.01.2007Despatch of a communication from the examining division (Time limit: M04)
04.06.2007Reply to a communication from the examining division
28.11.2007Communication of intention to grant the patent
16.05.2008Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
09.07.2008Fee for grant paid
09.07.2008Fee for publishing/printing paid
Opposition(s)18.06.2009No opposition filed within time limit [2009/35]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
09.07.2008Request for further processing filed
09.07.2008Full payment received (date of receipt of payment)
Fees paidRenewal fee
31.07.2003Renewal fee patent year 03
02.08.2004Renewal fee patent year 04
01.08.2005Renewal fee patent year 05
31.07.2006Renewal fee patent year 06
31.07.2007Renewal fee patent year 07
31.07.2008Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE17.09.2008
CY17.09.2008
DK17.09.2008
FI17.09.2008
TR17.09.2008
SE17.12.2008
GR18.12.2008
PT17.02.2009
[2011/43]
Former [2010/47]BE17.09.2008
DK17.09.2008
FI17.09.2008
SE17.12.2008
GR18.12.2008
PT17.02.2009
Former [2010/09]BE17.09.2008
DK17.09.2008
FI17.09.2008
SE17.12.2008
PT17.02.2009
Former [2009/34]BE17.09.2008
DK17.09.2008
FI17.09.2008
PT17.02.2009
Former [2009/25]BE17.09.2008
FI17.09.2008
PT17.02.2009
Former [2009/19]BE17.09.2008
FI17.09.2008
Former [2009/15]FI17.09.2008
Cited inInternational search[Y]DE3314479  (SANDOZ AG [DE]) [Y] 1-9 * claim 1 * * page 8, line 12 - page 10, line 3 *;
 [Y]EP0153277  (SANDOZ AG [CH], et al) [Y] 1-9 * claims 1,8 *;
 [Y]WO9801127  (BIOCHEMIE GMBH [AT], et al) [Y] 1-9* claims 1-13 *;
 [X]  - H. EGGER, H. REINSHAGEN, "New pleuromutilin derivatives with enhanced antimicribial activity II. Structure-activity correlations", THE JOURNAL OF ANTIBIOTICS, (1976), vol. 29, no. 9, pages 923 - 927, XP001022902 [X] 2,5-9 * see compounds 56 and 57 *
 [X]  - H. EGGER, H. REINSHAGEN, "New pleuromutilin derivatives with enhanced antimicrobial activity I. Synthesis", THE JOURNAL OF ANTIBIOTICS, (1976), vol. 29, no. 9, pages 915 - 922, XP001022901 [X] 2,5-9 * see compounds 56 and 57 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.